Lung ultrasound in diagnosis and follow up of community acquired pneumonia in infants younger than 1‐year old

Omran, Ahmed; Eesai, Samah; Ibrahim, Mohammed Ahmed; El-Sharkawy, Sonya

doi:10.1111/crj.12790

Cited by 13 publications

(13 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Ianniello et al highlighted that LUS after 5 days showed a complete disappearance or decrease in size of subpleural pulmonary parenchymal lesions in 84.6% of their patients. Omran et al reported the complete regression or diminished size in 81.6% of patients on day 5 of treatment. We showed that children with noncomplicated CAP had an overall improvement already at T48 LUS control, while this trend was not described in children with complicated CAP.…”

Section: Discussionmentioning

confidence: 99%

Lung ultrasound features of children with complicated and noncomplicated community acquired pneumonia: A prospective study

Musolino

Tomà

Supino

et al. 2019

Pediatric Pulmonology

View full text Add to dashboard Cite

Objective The purpose of this study was to describe lung ultrasound (LUS) findings at baseline and 48 hours after the beginning of treatment and evaluate how they correlate with outcome Design We prospectively analyzed patients from 1 month to 17 years of age with community acquired pneumonia (CAP) evaluated at a tertiary level pediatric hospital. At baseline and 48 hours after the beginning of treatment, history, clinical examination, laboratory testing, chest X‐ray, and LUS were performed. Results One hundred one children were enrolled in the study (13 with complicated CAP). At baseline those who developed complications presented a larger size of the subpleural pulmonary parenchymal lesions (P = .001) often associated with a complex pleural effusion (63.6%, P = .013). Those with an uncomplicated CAP presented an air, arboriform, superficial and dynamic bronchogram, as opposed to complicated CAP which had an air and liquid bronchogram, deep, fixed (P = .001). At the 48‐hour control in the noncomplicated CAP group, bronchogram was more frequently superficial and dynamic (P = .050). Pleural effusion disappeared in half cases (P = .050). In all patients, neutrophilic leucocytosis with increased C‐reactive protein was detected and decreased at control (P = .001). The linear regression analyses showed the switch from a deep to a superficial bronchogram as the only explanatory variable (r = 0.97, R2 = 0.94, P = .001, t = 10.73). Conclusions Our study describe early LUS features of CAP that might be able to predict the development of complicated CAP.

show abstract

Section: Discussionmentioning

confidence: 99%

Lung ultrasound features of children with complicated and noncomplicated community acquired pneumonia: A prospective study

Musolino

Tomà

Supino

et al. 2019

Pediatric Pulmonology

View full text Add to dashboard Cite

show abstract

“…Besides the diagnosis of lung lesions in COVID-19, LUS can also diagnose and differentially diagnose the dyspnea caused by COVID-19 through BLUE and FALLS schemes [16][17][18]. Because LUS is non-radiative and repeatable, it can also be used to keep track of the patient's progress [19,20]. Coupled with the development and application of remote robotic ultrasound, such problems as lack of sonographers and backward equipment in the SARS-Cov-2 quarantine zone can be greatly alleviated.…”

Section: Discussionmentioning

confidence: 99%

Application Value of Lung Ultrasound in Asymptomatic Patients with Confirmed COVID-19

Lin¹,

Zhang²,

Kou³

et al. 2020

Advanced Ultrasound in Diagnosis and Therapy

View full text Add to dashboard Cite

To investigate the value of lung ultrasound (LUS) in asymptomatic patients with confirmed COVID-19. Methods:A retrospective analysis was performed on nine patients in a designated isolation hospital in Sanya from February 22nd, 2020 to February 23rd, 2020. All patients were confirmed with COVID-19 pneumonia by PCR test, but none had the typical symptoms of COVID-19. All patients first underwent LUS examination and then chest computed tomography (CT) scanning. The application value of LUS in asymptomatic confirmed patients with COVID-19 was evaluated, compared with chest CT which was regarded as the golden standard.Results: Among nine asymptomatic patients with COVID-19, there were two cases (22.22%) with abnormal ultrasonic manifestations, of which one (11.11%) showed a fusion B3-line in zone 5 of the right lung, and the other showed localized pulmonary consolidation in zone 6 of the left lung. The remaining seven cases (77.78%) showed no abnormal changes in LUS, but only clear pleura sliding sign and A-line. Chest CT showed abnormal changes in three cases (33.33%). Two of them (22.22%) showed flocculent high-density shadow at the base of both lungs (especially in the right lung), while the other case showed ground-glass opacity with thickened interlobular septal in the left lower lobe, involving the pleura. There were no abnormalities on chest CT of the remaining six cases (66.67%). The two (22.22%) LUS-positive patients were in complete coincidence with CT-positive patients. This study showed that the coincidence rate of the two examination methods was 88.89%. Taking chest CT as golden standard, the sensitivity, specificity, positive predictive value, negative predictive value, and Kappa value of lung ultrasound in the diagnosis of COVID-19 were 66.67%, 100%, 100%, 85.71%, and 0.727, respectively. Conclusion:LUS can evaluate lung lesions in asymptomatic patients with COVID-19. Compared with chest CT, the diagnostic coincidence rate and diagnostic consistency of LUS are relatively higher. For this asymptomatic type of patient, ultrasound can be used as a diagnosis method, which can avoid the risk of radiation exposure in a short period of time. As a rapid and dynamic assessment method, LUS can cooperate with remote consultation to provide timely and accurate guidance for clinical diagnosis and treatment when necessary.

show abstract

“…After 5 days of treatment, the lung US showed a complete disappearance or a decrease in the size of consolidation patches in 84.6% of their patients, and 15% showed disease stability or an insubstantial decrease in size. Similarly, Omran et al described the complete regression or diminished size of the consolidations in 81.6% of patients on the fifth day of treatment, confirmed by the patients’ clinical improvement. The 7 infants (14.3%) who showed increased‐size consolidation patches had weaker clinical improvement and needed prolonged hospital stays.…”

Section: Discussionmentioning

confidence: 99%

The Use of Lung Ultrasound to Monitor the Antibiotic Response of Community‐Acquired Pneumonia in Children: A Preliminary Hypothesis

Buonsenso

Brancato

Valentini

et al. 2019

J of Ultrasound Medicine

View full text Add to dashboard Cite

Community‐acquired pneumonia (CAP) is associated with high morbidity and mortality among children worldwide. Over the last 10 years, lung ultrasound (US) has been widely studied as an alternative diagnostic tool for adult and pediatric CAP with excellent results. In this case series, we describe clinical and laboratory results as well as detailed lung US findings in 6 children with CAP, showing the potential use of lung US in monitoring the response to antibiotic therapy.

show abstract

Lung ultrasound in diagnosis and follow up of community acquired pneumonia in infants younger than 1‐year old

Cited by 13 publications

References 32 publications

Lung ultrasound features of children with complicated and noncomplicated community acquired pneumonia: A prospective study

Lung ultrasound features of children with complicated and noncomplicated community acquired pneumonia: A prospective study

Application Value of Lung Ultrasound in Asymptomatic Patients with Confirmed COVID-19

The Use of Lung Ultrasound to Monitor the Antibiotic Response of Community‐Acquired Pneumonia in Children: A Preliminary Hypothesis

Contact Info

Product

Resources

About